ClinicalTrials.gg

Pneumonia, Ventilator-Associated clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 420 studies for Pneumonia, Ventilator-Associated across more than 10 countries. 83 are recruiting or about to start. 340 of them are mainly about Pneumonia, Ventilator-Associated (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Status

Completed
235
Status unknown
53
Recruiting
47
Not yet recruiting
32
Terminated
32
Withdrawn
10

Phase

Phase 3
55
Phase 2
43
Phase 4
37
Phase 1
11
Early Phase 1
7

Where

France
80
United States
62
Egypt
28
China
26
Spain
25
Brazil
20

Who develops what

Add Pneumonia, Ventilator-Associated to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 1 program from 1 company, 0 with this as their studies’ main aim; 0 with a live phase 3 study; 1 primary completion in the next 12 months.

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
MeropenemRecent, repeated
Evidence
  • NCT07512596 · Sino Biopharmaceutical Limited · Phase 2 · live · background · “Meropenem for injection” · registered Mar 2026
  • NCT06168734 · Venatorx Pharmaceuticals, Inc. · Phase 3 · comparator · “Meropenem” · registered Dec 2023
  • NCT03032380 · Shionogi · Phase 3 · comparator · “Meropenem” · registered Jan 2017
  • NCT02070757 · Merck & Co., Inc · Phase 3 · comparator · “Meropenem” · registered Feb 2014
Pfizer40% of its industry studiesUS: off-patent, 8 generics marketed22 studies

4 more in limited or earlier use — sign in to see them, free.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 1 program — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (1)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • Jul 2027 est.TQD3524 · Sino Biopharmaceutical Limited · Phase 2 named, not the main aimadded to MeropenemNCT07512596 Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria — primary endpoint: The proportion of subjects who achieved clinical cure · 48 enrolled

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Pneumonia, Ventilator-Associated studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Beta-lactamase inhibitors 7 · Statins 3

Coming up

29studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 47 Pneumonia, Ventilator-Associated studies recruiting now, 36 (77%) set no upper age limit and 6 (13%) stop at 75 or younger. 6 (13%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (9%) take healthy volunteers.

Recruiting studies that take each age, of 47
AgeWomenMen
103 (6%)3 (6%)
1842 (89%)42 (89%)
3041 (87%)41 (87%)
4041 (87%)41 (87%)
5041 (87%)41 (87%)
6541 (87%)41 (87%)
7541 (87%)41 (87%)
8540 (85%)40 (85%)

Across all 420 studies, recruiting or not: 16% stop at 75 or younger and 12% at 65; 18% take children; 0% are for women only and 0% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Pneumonia, Ventilator-Associated studies take

Of 16 phase 3 interventional studies under Pneumonia, Ventilator-Associated, half reached primary completion within 43 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 343 mo26–59 · 16 studies——
Interventional, no phase20 mo10–36 · 83 studies—20 mo10–36 · 82 studies
Observational20 mo12–38 · 63 studies—20 mo12–38 · 63 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 420. Browse all 420 → or search them.